BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Das G, Damotte V, Gelfand JM, Bevan C, Cree BAC, Do L, Green AJ, Hauser SL, Bove R. Rituximab before and during pregnancy: A systematic review, and a case series in MS and NMOSD. Neurol Neuroimmunol Neuroinflamm 2018;5:e453. [PMID: 29564373 DOI: 10.1212/NXI.0000000000000453] [Cited by in Crossref: 88] [Cited by in F6Publishing: 36] [Article Influence: 29.3] [Reference Citation Analysis]
Number Citing Articles
1 Esteve-Solé A, Luo Y, Vlagea A, Deyà-Martínez Á, Yagüe J, Plaza-Martín AM, Juan M, Alsina L. B Regulatory Cells: Players in Pregnancy and Early Life. Int J Mol Sci 2018;19:E2099. [PMID: 30029515 DOI: 10.3390/ijms19072099] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
2 Gold SM, Willing A, Leypoldt F, Paul F, Friese MA. Sex differences in autoimmune disorders of the central nervous system. Semin Immunopathol 2019;41:177-88. [PMID: 30361800 DOI: 10.1007/s00281-018-0723-8] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 14.0] [Reference Citation Analysis]
3 Miranda-Acuña J, Rivas-Rodríguez E, Levy M, Ansari M, Stone R, Patel V, Amezcua L. Rituximab during pregnancy in neuromyelitis optica: A case report. Neurol Neuroimmunol Neuroinflamm 2019;6:e542. [PMID: 30800724 DOI: 10.1212/NXI.0000000000000542] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 3.5] [Reference Citation Analysis]
4 Razaz N, Piehl F, Frisell T, Langer-Gould AM, McKay KA, Fink K. Disease activity in pregnancy and postpartum in women with MS who suspended rituximab and natalizumab. Neurol Neuroimmunol Neuroinflamm 2020;7:e903. [PMID: 33087582 DOI: 10.1212/NXI.0000000000000903] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
5 Altintas A, Dargvainiene J, Schneider-Gold C, Asgari N, Ayzenberg I, Ciplea AI, Junker R, Leypoldt F, Wandinger KP, Hellwig K. Gender issues of antibody-mediated diseases in neurology: (NMOSD/autoimmune encephalitis/MG). Ther Adv Neurol Disord 2020;13:1756286420949808. [PMID: 32922516 DOI: 10.1177/1756286420949808] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Huang Q, Wang J, Zhou Y, Yang H, Wang Z, Yan Z, Long Y, Yin J, Feng H, Li C, Lu Z, Hu X, Qiu W. Low-Dose Mycophenolate Mofetil for Treatment of Neuromyelitis Optica Spectrum Disorders: A Prospective Multicenter Study in South China. Front Immunol 2018;9:2066. [PMID: 30258442 DOI: 10.3389/fimmu.2018.02066] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
7 Tisovic K, Amezcua L. Women's Health: Contemporary Management of MS in Pregnancy and Post-Partum. Biomedicines 2019;7:E32. [PMID: 31010259 DOI: 10.3390/biomedicines7020032] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
8 Smith JB, Hellwig K, Fink K, Lyell DJ, Piehl F, Langer-Gould A. Rituximab, MS, and pregnancy. Neurol Neuroimmunol Neuroinflamm 2020;7:e734. [PMID: 32358226 DOI: 10.1212/NXI.0000000000000734] [Cited by in Crossref: 18] [Cited by in F6Publishing: 5] [Article Influence: 18.0] [Reference Citation Analysis]
9 Tugizova M, Vlahovic L, Tomczak A, Wetzel NS, Han MH. New Therapeutic Landscape in Neuromyelitis Optica. Curr Treat Options Neurol 2021;23:13. [PMID: 33814893 DOI: 10.1007/s11940-021-00667-3] [Reference Citation Analysis]
10 Yap SM, Dillon M, Crowley RK, McGuigan C. Alemtuzumab-related thyroid disease in people with multiple sclerosis is associated with age and brainstem phenotype at disease onset. Mult Scler J Exp Transl Clin 2020;6:2055217320933928. [PMID: 32612846 DOI: 10.1177/2055217320933928] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Beltagy A, Aghamajidi A, Trespidi L, Ossola W, Meroni PL. Biologics During Pregnancy and Breastfeeding Among Women With Rheumatic Diseases: Safety Clinical Evidence on the Road. Front Pharmacol 2021;12:621247. [PMID: 34122062 DOI: 10.3389/fphar.2021.621247] [Reference Citation Analysis]
12 Krysko KM, Bove R, Dobson R, Jokubaitis V, Hellwig K. Treatment of Women with Multiple Sclerosis Planning Pregnancy. Curr Treat Options Neurol 2021;23:11. [PMID: 33814892 DOI: 10.1007/s11940-021-00666-4] [Reference Citation Analysis]
13 Brancati S, Gozzo L, Longo L, Vitale DC, Drago F. Rituximab in Multiple Sclerosis: Are We Ready for Regulatory Approval? Front Immunol 2021;12:661882. [PMID: 34295328 DOI: 10.3389/fimmu.2021.661882] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Borisow N, Mori M, Kuwabara S, Scheel M, Paul F. Diagnosis and Treatment of NMO Spectrum Disorder and MOG-Encephalomyelitis. Front Neurol 2018;9:888. [PMID: 30405519 DOI: 10.3389/fneur.2018.00888] [Cited by in Crossref: 105] [Cited by in F6Publishing: 96] [Article Influence: 35.0] [Reference Citation Analysis]
15 Krysko KM, LaHue SC, Anderson A, Rutatangwa A, Rowles W, Schubert RD, Marcus J, Riley CS, Bevan C, Hale TW, Bove R. Minimal breast milk transfer of rituximab, a monoclonal antibody used in neurological conditions. Neurol Neuroimmunol Neuroinflamm. 2020;7:e637. [PMID: 31719115 DOI: 10.1212/nxi.0000000000000637] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
16 Zhu W, Zhang Y, Wang Z, Fu Y, Yan Y. Monoclonal Antibody-Based Treatments for Neuromyelitis Optica Spectrum Disorders: From Bench to Bedside. Neurosci Bull 2020;36:1213-24. [PMID: 32533450 DOI: 10.1007/s12264-020-00525-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
17 Oertel FC, Schließeit J, Brandt AU, Paul F. Cognitive Impairment in Neuromyelitis Optica Spectrum Disorders: A Review of Clinical and Neuroradiological Features. Front Neurol 2019;10:608. [PMID: 31258505 DOI: 10.3389/fneur.2019.00608] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 11.0] [Reference Citation Analysis]
18 Fragoso YD, Adoni T, Brooks JBB, Finkelsztejn A, da Gama PD, Grzesiuk AK, Marques VD, Parolin MFK, Sato HK, Varela DL, Vasconcelos CCF. Practical Evidence-Based Recommendations for Patients with Multiple Sclerosis Who Want to Have Children. Neurol Ther 2018;7:207-32. [PMID: 30167914 DOI: 10.1007/s40120-018-0110-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
19 Krysko KM, Graves JS, Dobson R, Altintas A, Amato MP, Bernard J, Bonavita S, Bove R, Cavalla P, Clerico M, Corona T, Doshi A, Fragoso Y, Jacobs D, Jokubaitis V, Landi D, Llamosa G, Longbrake EE, Maillart E, Marta M, Midaglia L, Shah S, Tintore M, van der Walt A, Voskuhl R, Wang Y, Zabad RK, Zeydan B, Houtchens M, Hellwig K. Sex effects across the lifespan in women with multiple sclerosis. Ther Adv Neurol Disord 2020;13:1756286420936166. [PMID: 32655689 DOI: 10.1177/1756286420936166] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 13.0] [Reference Citation Analysis]
20 Rankin K, Bove R. Caring for Women with Multiple Sclerosis Across the Lifespan. Curr Neurol Neurosci Rep 2018;18:36. [PMID: 29789964 DOI: 10.1007/s11910-018-0846-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
21 Gomez-Lopez N, Romero R, Hassan SS, Bhatti G, Berry SM, Kusanovic JP, Pacora P, Tarca AL. The Cellular Transcriptome in the Maternal Circulation During Normal Pregnancy: A Longitudinal Study. Front Immunol 2019;10:2863. [PMID: 31921132 DOI: 10.3389/fimmu.2019.02863] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 8.0] [Reference Citation Analysis]
22 Berenguer-Ruiz L, Gimenez-Martinez J, Palazón-Bru A, Sempere AP. Relapses and obstetric outcomes in women with multiple sclerosis planning pregnancy. J Neurol 2019;266:2512-7. [PMID: 31256279 DOI: 10.1007/s00415-019-09450-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
23 Sica A, Vitiello P, Papa A, Calogero A, Sagnelli C, Casale D, Mottola M, Svanera G, Dodaro CA, Martinelli E, Troiani T, Ciardiello F, Casale B. Use of Rituximab in NHL Malt Type Pregnant in I° Trimester for Two Times. Open Med (Wars) 2019;14:757-60. [PMID: 31844674 DOI: 10.1515/med-2019-0087] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
24 Perrotta K, Kiernan E, Bandoli G, Manaster R, Chambers C. Pregnancy outcomes following maternal treatment with rituximab prior to or during pregnancy: a case series. Rheumatol Adv Pract 2021;5:rkaa074. [PMID: 33521513 DOI: 10.1093/rap/rkaa074] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
25 Graf J, Albrecht P, Goebels N, Aktas O, Hartung HP. [Ocrelizumab for treatment of multiple sclerosis]. Nervenarzt 2020;91:722-34. [PMID: 32524163 DOI: 10.1007/s00115-020-00937-6] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Evoli A, Antonini G, Antozzi C, DiMuzio A, Habetswallner F, Iani C, Inghilleri M, Liguori R, Mantegazza R, Massa R, Pegoraro E, Ricciardi R, Rodolico C. Italian recommendations for the diagnosis and treatment of myasthenia gravis. Neurol Sci 2019;40:1111-24. [PMID: 30778878 DOI: 10.1007/s10072-019-03746-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 8.5] [Reference Citation Analysis]
27 Joubert B, García-Serra A, Planagumà J, Martínez-Hernandez E, Kraft A, Palm F, Iizuka T, Honnorat J, Leypoldt F, Graus F, Dalmau J. Pregnancy outcomes in anti-NMDA receptor encephalitis: Case series. Neurol Neuroimmunol Neuroinflamm 2020;7:e668. [PMID: 31948997 DOI: 10.1212/NXI.0000000000000668] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
28 Canibaño B, Ali M, Mesraoua B, Melikyan G, Al Hail H, Ibrahim F, Hanssens Y, Deleu D. Severe rebound disease activity after fingolimod withdrawal in a pregnant woman with multiple sclerosis managed with rituximab: A case study. Case Rep Womens Health 2020;25:e00162. [PMID: 31867224 DOI: 10.1016/j.crwh.2019.e00162] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
29 Ponticelli C, Zaina B, Moroni G. Planned Pregnancy in Kidney Transplantation. A Calculated Risk. J Pers Med 2021;11:956. [PMID: 34683097 DOI: 10.3390/jpm11100956] [Reference Citation Analysis]
30 Borisow N, Hellwig K, Paul F. Neuromyelitis optica spectrum disorders and pregnancy: relapse-preventive measures and personalized treatment strategies. EPMA J 2018;9:249-56. [PMID: 30174761 DOI: 10.1007/s13167-018-0143-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
31 Yeh WZ, Widyastuti PA, Van der Walt A, Stankovich J, Havrdova E, Horakova D, Vodehnalova K, Ozakbas S, Eichau S, Duquette P, Kalincik T, Patti F, Boz C, Terzi M, Yamout BI, Lechner-Scott J, Sola P, Skibina OG, Barnett M, Onofrj M, Sá MJ, McCombe PA, Grammond P, Ampapa R, Grand'Maison F, Bergamaschi R, Spitaleri DLA, Van Pesch V, Cartechini E, Hodgkinson S, Soysal A, Saiz A, Gresle M, Uher T, Maimone D, Turkoglu R, Hupperts RM, Amato MP, Granella F, Oreja-Guevara C, Altintas A, Macdonell RA, Castillo-Trivino T, Butzkueven H, Alroughani R, Jokubaitis VG; MSBase Study Group. Natalizumab, Fingolimod and Dimethyl Fumarate Use and Pregnancy-Related Relapse and Disability in Women With Multiple Sclerosis. Neurology 2021:10. [PMID: 33879599 DOI: 10.1212/WNL.0000000000012084] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Busse M, Campe KJ, Nowak D, Schumacher A, Plenagl S, Langwisch S, Tiegs G, Reinhold A, Zenclussen AC. IL-10 producing B cells rescue mouse fetuses from inflammation-driven fetal death and are able to modulate T cell immune responses. Sci Rep 2019;9:9335. [PMID: 31249364 DOI: 10.1038/s41598-019-45860-2] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 10.5] [Reference Citation Analysis]
33 Boulay H, Mazaud-Guittot S, Supervielle J, Chemouny JM, Dardier V, Lacroix A, Dion L, Vigneau C. Maternal, foetal and child consequences of immunosuppressive drugs during pregnancy in women with organ transplant: a review. Clin Kidney J 2021;14:1871-8. [PMID: 34345409 DOI: 10.1093/ckj/sfab049] [Reference Citation Analysis]
34 Bonek K, Roszkowski L, Massalska M, Maslinski W, Ciechomska M. Biologic Drugs for Rheumatoid Arthritis in the Context of Biosimilars, Genetics, Epigenetics and COVID-19 Treatment. Cells 2021;10:323. [PMID: 33557301 DOI: 10.3390/cells10020323] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Schumacher A, Zenclussen AC. Human Chorionic Gonadotropin-Mediated Immune Responses That Facilitate Embryo Implantation and Placentation. Front Immunol 2019;10:2896. [PMID: 31921157 DOI: 10.3389/fimmu.2019.02896] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 7.5] [Reference Citation Analysis]
36 Mao-Draayer Y, Thiel S, Mills EA, Chitnis T, Fabian M, Katz Sand I, Leite MI, Jarius S, Hellwig K. Neuromyelitis optica spectrum disorders and pregnancy: therapeutic considerations. Nat Rev Neurol 2020;16:154-70. [PMID: 32080393 DOI: 10.1038/s41582-020-0313-y] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 21.0] [Reference Citation Analysis]